PMID: 9652825Jul 4, 1998Paper

Immunoglobulin prolongs survival of pig kidneys perfused ex vivo with human blood

Scandinavian Journal of Immunology
A E FianeT E Mollnes

Abstract

Intravenous immunoglobulin (IVIG) (Octagam), was used to determine the effect on hyperacute rejection in an ex vivo xenograft model. Six pig kidneys were perfused with IVIG and fresh human AB blood, and six control pig kidneys were simultaneously perfused with albumin and blood from the same donation. The survival of the IVIG-perfused xenografts (median, 6.5 h) was significantly (P = 0.03) longer than the albumin-perfused xenografts (median, 3.5 h). Complement was activated in both groups. The administration of IVIG to the perfused blood resulted in immediate and significantly higher complement activation in the fluid phase as compared with the albumin group. At rejection the fluid phase complement activation was higher in the IVIG group than in the albumin group for C1rs/C1inh complexes, C4bc, Bb and TCC. At the time of rejection both the albumin and the IVIG group demonstrated interstitial tubular haemorrhage, vasculitis or necrosis of glomerular capillaries and glomerular microthrombi. IgM, C1q, C3c, C4 and fibrin were located in arteries and glomeruli and IgG in the interstitium in both groups at rejection. The fluid phase findings are consistent with a modulatory effect of IVIG on complement activation by deviating the cla...Continue Reading

References

Mar 14, 1992·Lancet·W H Reinhart, P E Berchtold
Sep 1, 1992·Immunopharmacology·A P Dalmasso
Feb 23, 1991·Lancet·J SchifferliK Davies
Jan 9, 1992·The New England Journal of Medicine·J M Dwyer
Dec 1, 1988·Transplantation·S MiyagawaH Kitamura
May 1, 1972·Journal of Applied Physiology·W Van Beaumont
Sep 1, 1995·Nature Medicine·E Cozzi, D J White
Nov 1, 1995·The Journal of Clinical Investigation·J C MageeJ L Platt
Feb 1, 1994·Pediatric Research·E W NielsenT E Mollnes
May 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M Sykes
Aug 15, 1996·Transplantation·J H Lawson, J L Platt
Aug 1, 1996·Immunology Today·J A Frearson, D R Alexander

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.